| pubmed-article:11784625 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11784625 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11784625 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
| pubmed-article:11784625 | lifeskim:mentions | umls-concept:C0683150 | lld:lifeskim |
| pubmed-article:11784625 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
| pubmed-article:11784625 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:11784625 | lifeskim:mentions | umls-concept:C0332514 | lld:lifeskim |
| pubmed-article:11784625 | lifeskim:mentions | umls-concept:C1453836 | lld:lifeskim |
| pubmed-article:11784625 | pubmed:issue | 9299 | lld:pubmed |
| pubmed-article:11784625 | pubmed:dateCreated | 2002-1-10 | lld:pubmed |
| pubmed-article:11784625 | pubmed:abstractText | The plasma concentration of asymmetrical dimethylarginine (ADMA), an inhibitor of nitric-oxide synthase, which has been linked to endothelial dysfunction and atherosclerosis in the general population, is raised in patients with end-stage renal disease and could contribute to the high cardiovascular risk in patients with chronic renal failure. We investigated the relation between cardiovascular risk factors and plasma ADMA concentration in a cohort of haemodialysis patients (n=225), and tested the predictive power of ADMA for mortality and cardiovascular outcomes. | lld:pubmed |
| pubmed-article:11784625 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11784625 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11784625 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11784625 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11784625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11784625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11784625 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11784625 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:ZoccaliCC | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:FrölichJJ | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:MallamaciFF | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:FermoII | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:MalatinoLL | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:Bode-BögerSS | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:TripepiGG | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:BenedettoFF | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:BellanuovaII | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:CataliottiAA | lld:pubmed |
| pubmed-article:11784625 | pubmed:author | pubmed-author:BögerRR | lld:pubmed |
| pubmed-article:11784625 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11784625 | pubmed:volume | 358 | lld:pubmed |
| pubmed-article:11784625 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11784625 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11784625 | pubmed:pagination | 2113-7 | lld:pubmed |
| pubmed-article:11784625 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:meshHeading | pubmed-meshheading:11784625... | lld:pubmed |
| pubmed-article:11784625 | pubmed:articleTitle | Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. | lld:pubmed |
| pubmed-article:11784625 | pubmed:affiliation | CNR Centre of Clinical Physiology and Renal Unit, C, Reggio, Italy. | lld:pubmed |
| pubmed-article:11784625 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11784625 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11784625 | lld:pubmed |
